
Oral Midodrine Administration During the First 24 Hours of Sepsis to Reduce the Need of Vasoactive Agents: Placebo-Controlled Feasibility Clinical Trial
Author(s) -
Amos Lal,
Vrinda Trivedi,
Mahrukh Rizvi,
Amy Amsbaugh,
Melissa Myers,
Khaled Saleh,
Rahul Kashyap,
Ognjen Gajić
Publication year - 2021
Publication title -
critical care explorations
Language(s) - English
Resource type - Journals
ISSN - 2639-8028
DOI - 10.1097/cce.0000000000000382
Subject(s) - midodrine , medicine , placebo , anesthesia , randomized controlled trial , sepsis , bolus (digestion) , blood pressure , orthostatic vital signs , alternative medicine , pathology